Home Data Calendar Blog

VTRS

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Common Stock Value 12.1012.1012.1012.1012.1012.1012.1012.10NANA0.00NA0.00NANA
Weighted Average Number Of Diluted Shares Outstanding 1218.101217.101213.10NA1212.601208.801207.50NA517.70517.20NA517.00NANANA
Weighted Average Number Of Shares Outstanding Basic 1212.501212.301210.50NA1209.301208.801207.50NA516.90516.90NA516.400.00NA0.00
Earnings Per Share Basic 0.290.260.33-0.220.26-0.23-0.86-1.590.360.08NA0.040.00NA0.00
Earnings Per Share Diluted 0.290.260.33-0.220.26-0.23-0.86-1.590.360.08NA0.04NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Revenue From Contract With Customer Excluding Assessed Tax 4067.404105.404178.204331.304520.504561.704400.103587.702948.102695.900.002588.200.000.000.00
Revenues 4078.204116.804191.704341.604536.604577.804430.303623.502972.102731.200.002619.200.000.000.00
Cost Of Goods And Services Sold 2329.802413.502420.502795.202962.503250.103303.002917.101813.601705.50NA1713.10NANANA
Gross Profit 1748.401703.301771.201546.401574.101327.701127.30706.401158.501025.70NA906.10NANANA
Operating Expenses 1188.301154.601063.801624.001216.501375.501393.501587.50807.10891.500.00721.400.000.000.00
Research And Development Expense 174.90162.60142.30267.20152.10147.70184.10154.80129.80156.30NA114.20NANANA
Selling General And Administrative Expense 1017.30981.10915.301082.901055.001204.801186.501361.40658.40719.40NA605.40NANANA
Operating Income Loss 560.10548.70707.40-77.60357.60-47.80-266.20-881.10351.40134.20NA184.70NANANA
Interest Expense 153.20145.90146.20148.20151.90167.10169.00421.80117.30116.205.30119.90NANANA
Income Tax Expense Benefit 73.2075.40128.3059.90-111.6060.10596.300.7055.90-19.40-0.309.900.000.000.00
Other Comprehensive Income Loss Net Of Tax -859.90-838.20-316.70-272.40-266.90180.60-527.60565.80601.10428.600.00-656.300.000.000.00
Comprehensive Income Net Of Tax -505.60-524.3082.50NA44.60-98.60-1565.20NA786.80468.00-0.90-635.500.000.000.00
Net Income Loss Available To Common Stockholders Basic 354.30313.90399.20NA311.50-279.20-1037.60NA185.7039.40NA20.80NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Assets 48662.6051125.1053466.9054842.8056070.4057984.1058979.2061553.00NANA11411.80NA0.00NANA
Liabilities 29480.3031319.7033019.2034350.1034929.1036777.2037564.5038598.90NANA11413.00NA0.00NANA
Liabilities And Stockholders Equity 48662.6051125.1053466.9054842.8056070.4057984.1058979.2061553.00NANA11411.80NA0.00NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Assets Current 10487.8011176.5011744.3010902.9011308.4011749.8012318.5012867.50NANA11411.80NA0.00NANA
Cash And Cash Equivalents At Carrying Value 646.70664.70752.40701.20756.60673.90806.90844.40664.50323.60NA572.40NANANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 650.40669.40757.40706.20761.70679.10813.10850.00667.10324.700.00587.900.000.000.00
Accounts Receivable Net Current 3333.903736.204093.904266.404345.504478.704529.004843.80NANANANANANANA
Receivables Net Current 2829.803182.903556.903774.403841.503880.403889.603891.30NANANANANANANA
Inventory Net 3380.403612.503797.303977.704081.904487.604942.205471.90NANANANANANANA
Other Assets Current 1132.201145.401208.101467.101652.901709.601591.501236.10NANA0.20NANANANA
Prepaid Expense And Other Assets Current 1700.401697.701763.601957.602124.402109.602040.401707.40NANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Property Plant And Equipment Gross 5018.605041.405092.505589.105597.805663.105615.705721.90NANANANANANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 1979.601957.501942.302400.502483.802491.702368.802262.00NANANANANANANA
Amortization Of Intangible Assets 615.90634.10648.10664.70671.50681.60684.40534.90368.10351.60NA351.20NANANA
Property Plant And Equipment Net 3039.003083.903150.203188.603114.003171.403246.903459.90NANANANANANANA
Goodwill 10054.6010523.0010978.8012113.7012169.5011990.4011907.3012347.00NANANANANANANA
Indefinite Lived Intangible Assets Excluding Goodwill 42.5043.8045.7046.5079.8079.8080.7080.70NANANANANANANA
Intangible Assets Net Excluding Goodwill 23013.3024101.1025251.8026134.2026987.0027863.7028489.6029683.20NANANANANANANA
Finite Lived Intangible Assets Net 22970.8024057.3025206.1026087.7026907.2027783.9028408.9029602.50NANANANANANANA
Other Assets Noncurrent 963.90997.401056.001170.701039.601025.101019.601047.50NANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Liabilities Current 6521.407681.209642.909884.4010103.9010132.609978.1010562.90NANA27.80NA0.00NANA
Debt Current 755.00758.602595.401860.301881.002148.402255.302256.30NANANANANANANA
Long Term Debt Current 763.80768.202606.101877.501908.102184.402300.202308.50NANANANANANANA
Other Accrued Liabilities Current 1001.401205.001388.601254.601333.601280.801753.201973.20NANANANANANANA
Accrued Income Taxes Current 106.70125.70177.80236.90198.00636.00752.00288.60NANANANANANANA
Other Liabilities Current 3504.703812.404426.304619.604631.304211.504845.804960.70NANA27.80NANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Long Term Debt Noncurrent 18724.5019206.4018762.5019717.1019854.3020917.0022102.2022429.20NANA11385.20NANANANA
Deferred Income Tax Liabilities Net 2489.302617.902729.502815.002918.003485.703014.603123.70NANANANANANANA
Other Liabilities Noncurrent 1745.101814.201884.301933.602052.902241.902469.602483.10NANANANANANANA
Operating Lease Liability Noncurrent 179.30192.20191.70200.90213.70208.60217.20229.50NANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19182.3019805.4020447.7020492.7021141.3021206.9021414.7022954.1012547.9011746.20NA11262.70NANANA
Common Stock Value 12.1012.1012.1012.1012.1012.1012.1012.10NANA0.00NA0.00NANA
Additional Paid In Capital 18616.8018585.7018555.1018536.1018514.1018489.9018464.6018438.80NANA-0.30NA0.00NANA
Retained Earnings Accumulated Deficit 4312.504106.803941.503688.804087.003909.904323.605361.20NANA-0.90NA0.00NANA
Accumulated Other Comprehensive Income Loss Net Of Tax -3759.10-2899.20-2061.00-1744.30-1471.90-1205.00-1385.60-858.00-1423.80-2024.900.00-2453.500.00NANA
Stock Issued During Period Value New Issues 1.800.70NANANANANANANANANANANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 29.1029.4028.3022.5025.0031.0032.7029.4015.1015.30NA19.40NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Net Cash Provided By Used In Operating Activities 869.00802.501138.50523.101085.60559.40848.801230.801195.60670.600.00291.100.000.000.00
Net Cash Provided By Used In Investing Activities -115.00-82.10-66.90-219.10-118.20-16.80236.3011111.9011132.80-220.10-11411.60-145.600.000.000.00
Net Cash Provided By Used In Financing Activities -758.70-779.60-1009.00-349.20-877.50-685.50-1099.80-12017.70-12166.40-609.1011411.60-24.800.000.000.00

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Net Cash Provided By Used In Operating Activities 869.00802.501138.50523.101085.60559.40848.801230.801195.60670.600.00291.100.000.000.00
Depreciation Depletion And Amortization 699.50722.30736.00749.801017.101317.101422.50953.10432.30415.70NA415.00NANANA
Increase Decrease In Other Operating Capital Net 130.60136.90-132.70266.90306.10-261.10354.60130.20-131.6030.40NA-75.00NANANA
Increase Decrease In Accounts Receivable -241.2026.80115.509.80-183.8054.9059.80-106.00149.90-49.00NA-73.60NANANA
Increase Decrease In Inventories 169.50201.0069.1076.5010.10137.60203.40209.50256.60144.00NA131.80NANANA
Deferred Income Tax Expense Benefit -21.90-104.80-52.80-52.90147.00293.20288.40-161.20-90.70-75.80NA-43.90NANANA
Share Based Compensation 29.1029.4028.3022.5025.0031.0032.7029.4015.1015.30NA19.40NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Net Cash Provided By Used In Investing Activities -115.00-82.10-66.90-219.10-118.20-16.80236.3011111.9011132.80-220.10-11411.60-145.600.000.000.00
Payments To Acquire Property Plant And Equipment 103.9083.9064.50197.40121.0089.3049.50116.9038.2044.50NA43.40NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Net Cash Provided By Used In Financing Activities -758.70-779.60-1009.00-349.20-877.50-685.50-1099.80-12017.70-12166.40-609.1011411.60-24.800.000.000.00

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-06-28 2020-03-31 2020-03-29 2019-06-30 2019-03-31
Revenues 4078.204116.804191.704341.604536.604577.804430.303623.502972.102731.200.002619.200.000.000.00
Revenue From Contract With Customer Excluding Assessed Tax 4067.404105.404178.204331.304520.504561.704400.103587.702948.102695.900.002588.200.000.000.00
Operating, Developed Markets 2431.502479.102476.102560.802655.902640.402571.602378.602163.201982.70NA1986.40NANANA
Operating, Emerging Markets 678.90650.90705.20727.50792.50870.00754.70629.00471.00410.30NA343.50NANANA
Operating, Greater China 574.00548.30573.10503.80566.80550.30591.90190.6031.5022.70NA15.10NANANA
Operating, Japan Australia And New Zealand 383.00427.10423.80539.20505.30501.00481.90389.50282.40280.20NA243.20NANANA
Foreign Exchange Contract, Cash Flow Hedging, Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges -32.20-28.10-14.20-11.00-10.20-3.60-6.10NA-5.102.90NANANANANA
Foreign Exchange Contract, Reclassification Out Of Accumulated Other Comprehensive Income, Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges -32.20-28.10-14.20-11.00-10.20-3.60-6.10-2.50-5.102.90NA-0.10NANANA
Foreign Exchange Contract, Reclassification Out Of Accumulated Other Comprehensive Income, Accumulated Other Comprehensive Income -32.20-28.10-14.20-11.00-10.20-3.60-6.10-2.50-5.102.90NA-0.10NANANA
Amitiza 39.4044.1041.8054.0049.5052.1045.90NANANANANANANANA
Brands 2540.302483.102554.102611.902803.102701.702724.601859.001241.401073.00NA1061.50NANANA
Celebrex 82.2085.9085.2087.1086.0082.3089.00NANANANANANANANA
Complex G X And Biosimilars 320.20354.80390.80348.40332.00332.80328.90338.80352.30351.10NA253.30NANANA
Creon 76.4075.4074.7085.1081.1080.7069.90NANANANANANANANA
Dymista 38.6055.5044.0032.0035.0054.6040.30NANANANANANANANA
Effexor 64.2073.7077.5044.7079.5083.5076.60NANANANANANANANA
Epi Pen Auto Injectors 114.40106.5088.8054.40129.50104.10103.70NANANANANANANANA
Generics 1206.901267.501233.301371.001385.401527.201346.601389.901354.401271.80NA1273.40NANANA
Influvac 159.30NANA134.00161.20NANANANANANANANANANA
Lipitor 420.40405.60440.10390.30410.00398.30464.60NANANANANANANANA
Lyrica 156.50155.80171.70172.60175.60192.50187.80NANANANANANANANA
Norvasc 189.30203.00207.80188.80198.40209.80227.70NANANANANANANANA
Viagra 117.00115.10129.80121.40138.00134.80139.60NANANANANANANANA
Xalabrands 51.0042.7053.0054.0055.8058.3057.90NANANANANANANANA
Xanax 38.3037.2040.0044.4047.6048.8045.10NANANANANANANANA
Yupelri 53.4049.1043.7049.9039.4041.8036.90NANANANANANANANA
Zoloft 53.1062.5073.10101.0061.3070.9076.60NANANANANANANANA
Brands, Developed Markets 1327.701305.401298.701408.701522.701424.101403.701160.501013.20855.50NA891.50NANANA
Brands, Emerging Markets 429.10388.30436.70383.70414.50433.00446.00230.3080.9067.40NA64.70NANANA
Brands, Greater China 571.90546.30569.70500.90566.80549.20590.90186.7030.5022.00NA14.70NANANA
Brands, Japan Australia And New Zealand 211.60243.10249.00318.60299.10295.40284.00281.50116.80128.10NA90.60NANANA
Complex G X And Biosimilars, Developed Markets 295.00327.00364.10315.20305.10309.30312.00306.60325.80328.60NA241.60NANANA
Complex G X And Biosimilars, Emerging Markets 14.1015.4016.4018.4013.7013.708.0014.1018.1014.00NA3.20NANANA
Complex G X And Biosimilars, Greater China 0.200.30NANANANANA0.500.100.00NA0.10NANANA
Complex G X And Biosimilars, Japan Australia And New Zealand 10.9012.1010.3014.6013.209.808.9017.608.308.50NA8.40NANANA
Generics, Developed Markets 808.80846.70813.30836.90828.10907.00855.90911.50824.20798.60NA853.30NANANA
Generics, Emerging Markets 235.70247.20252.10325.40364.30423.30300.70384.60372.00328.90NA275.60NANANA
Generics, Greater China 1.901.703.402.700.001.101.003.400.900.70NA0.30NANANA
Generics, Japan Australia And New Zealand 160.50171.90164.50206.00193.00195.80189.0090.40157.30143.60NA144.20NANANA

Plots across concepts


IncomeStatement
Other Comprehensive Income Loss Net Of Tax
Expenses
Other Nonoperating Income Expense
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Operating Lease Right Of Use Asset
Current Assets
Cash And Cash Equivalents At Carrying Value
NonCurrent Assets
Operating Lease Right Of Use Asset
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Liabilities Current
Current Liabilities
Operating Lease Liability Current
Noncurrent Liabilities
Operating Lease Liability Noncurrent
Stockholders Equity
Accumulated Other Comprehensive Income Loss Net Of Tax
Per Share
Common Stock Dividends Per Share Cash Paid
CashFlow
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInOperatingActivities
Increase Decrease In Accounts Receivable
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInFinancingActivities
Net Cash Provided By Used In Financing Activities
Shares
Weighted Average Number Of Shares Outstanding Basic
OperatingLeaseLiability
Operating Lease Liability Current
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Accumulated Amortization
InventoryNet
Inventory Raw Materials Net Of Reserves

Line plots across dimensions of each concept


Operating Margin
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Operating  Marginus-gaap: Consolidation Items, us-gaap: Statement Business Segments
TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:DerivativeInstrumentRisk, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
('us-gaap:ForeignExchangeContract', 'us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Derivative Instrument Risk, us-gaap: Reclassification Out Of Accumulated Other Comprehensive Income, us-gaap: Statement Equity Components
us-gaap:OperatingIncomeLoss
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Operating Income Lossus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:InterestExpense
us-gaap:DerivativeInstrumentRisk, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
('us-gaap:InterestRateSwap', 'us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome', None)
Interest Expenseus-gaap: Derivative Instrument Risk, us-gaap: Reclassification Out Of Accumulated Other Comprehensive Income, us-gaap: Statement Equity Components
us-gaap:IncomeTaxExpenseBenefit
us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:StatementEquityComponents
(None, 'us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges')
Income Tax Expense Benefitus-gaap: Derivative Instruments Gain Loss By Hedging Relationship, us-gaap: Statement Equity Components
us-gaap:IncomeTaxExpenseBenefit
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
('us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome', None)
Income Tax Expense Benefitus-gaap: Reclassification Out Of Accumulated Other Comprehensive Income, us-gaap: Statement Equity Components
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel
(None, 'us-gaap:FairValueInputsLevel2')
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Asset Class, us-gaap: Fair Value By Fair Value Hierarchy Level
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:Goodwill
us-gaap:StatementBusinessSegments
(None,)
Goodwillus-gaap: Statement Business Segments
us-gaap:DebtCurrent
us-gaap:DebtInstrument
(None,)
Debt Currentus-gaap: Debt Instrument
us-gaap:LongTermDebt
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
(None, 'us-gaap:SeniorNotes')
Long Term Debtus-gaap: Debt Instrument, us-gaap: Longterm Debt Type
us-gaap:LongTermDebt
us-gaap:DebtInstrument
(None,)
Long Term Debtus-gaap: Debt Instrument
us-gaap:LongTermDebtNoncurrent
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
(None, 'us-gaap:SeniorNotes')
Long Term Debt Noncurrentus-gaap: Debt Instrument, us-gaap: Longterm Debt Type
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:DerivativeInstrumentRisk, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
('us-gaap:ForeignExchangeContract', 'us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Derivative Instrument Risk, us-gaap: Reclassification Out Of Accumulated Other Comprehensive Income, us-gaap: Statement Equity Components